Wednesday, April 23, 2014 3:54:52 PM
On February 14, 2014, Amarantus BioScience Holdings, Inc. (the “Company”) issued a Demand Promissory Note in the amount of $500,000 (the “Note”) to Dominion Capital LLC, an existing shareholder of the Company. The Note has a maturity date of the earlier of March 31, 2014 or demand, which may be extended at the option of the Company to August 14, 2014. The Note bears interest at the rate of 12% per annum and may be redeemed by the Company in cash.
http://ih.advfn.com/p.php?pid=nmona&article=61140538
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM